Article R5121-51-11
At the end of the Community arbitration procedure implemented in accordance with the provisions of Articles R. 5121-51-8 and R. 5121-51-9, the Director General of the Agence nationale de sécurité du m…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 5971–5980 of 22749 articles for “Art. Cass. com. 15 March 2011”
At the end of the Community arbitration procedure implemented in accordance with the provisions of Articles R. 5121-51-8 and R. 5121-51-9, the Director General of the Agence nationale de sécurité du m…
At the end of the procedures provided for in this sub-section, the marketing authorisation is issued or varied by the Director General of the Agence nationale de sécurité du médicament et des produits…
For the purposes of placing a custom-made medical device on the market, the manufacturer shall follow the procedure defined in Article R. 5211-51. The Director General of the Agence nationale de sécur…
Presenting medical devices that do not comply with the provisions of articles R. 5211-12 and R. 5211-17 at scientific or technical meetings, exhibitions or demonstrations without displaying a sign cle…
…tenariat in accordance with the procedures specified by the general regulations of the Autorité des marchés financiers.
…t company's decisions concerning the scheme are lawful. The General Regulations of the Autorité des marchés financiers shall specify the terms and conditions for the application of this I, in particul…
Each decision taken by the sole member in place of the meeting is recorded by him in the register provided for in the third paragraph of Article L. 223-31. The register is kept at the registered offic…
…imit may be temporarily exceeded. In this case, the management company will inform the Autorité des marchés financiers, the custodian and the fund's auditor of the reasons why the limit has been excee…
The Director General of the Agence nationale de sécurité du médicament et des produits de santé may prohibit the prescription and supply of a proprietary medicinal product and withdraw it from the mar…
When an application for authorisation concerns a generic veterinary medicinal product of a reference veterinary medicinal product which has not been authorised in France but which has been authorised…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More